ExtenZe Commercial featuring Ron Jeremy 2002

1 month ago
43

ExtenZe is an herbal nutritional supplement that claims to promote "natural male enhancement," a euphemism for penis enlargement. The product has faced multiple legal and regulatory issues, including false advertising lawsuits and warnings from the FDA regarding undeclared ingredients.

ExtenZe has been involved in several legal actions. In 2010, the company paid $6 million to settle a class-action false advertising lawsuit, and in 2006, it agreed to pay $300,000 in civil penalties for false advertising claims about penis enlargement.
Additionally, in 2018, the FDA warned consumers not to purchase ExtenZe Plus due to the presence of sildenafil, the active ingredient in Viagra, which can cause dangerous interactions with certain medications.

The product contains various ingredients, including DHEA, yohimbe extract, and others, which have been associated with potential side effects such as increased heart rate, nausea, and more severe reactions like seizures and hallucinations.
Moreover, ExtenZe has been banned in sports due to its DHEA content, which is a performance-enhancing drug.

Despite its marketing, there is no scientific evidence supporting the effectiveness of ExtenZe for erectile dysfunction or penis enlargement. The FDA has not approved the product for these purposes, and multiple sources indicate that the claims made by the manufacturer are unsubstantiated.

ExtenZe is available in various forms, including pills and liquid shots, and is sold in over 75,000 retail stores. It is manufactured by BIOTAB Nutraceuticals, Inc., and marketed by Maximizer Health Products.
The product is also available on online platforms like Amazon, where it is sold as a male enhancement supplement with claims of boosting testosterone and enhancing sexual performance.

In summary, ExtenZe is a controversial supplement with a history of legal and regulatory issues, no proven efficacy for its claimed benefits, and potential health risks due to its ingredients.

Loading 1 comment...